Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4Neoplasms 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Lymphoma, Follicular 2Lung Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Thyroid Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Liver Metastases 1Liver Malignancy 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Neoplasms 1Disease 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Brain Neoplasms 1Bile Duct Neoplasms 1

Interventions

sintilimab 1regorafenib 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Liver Metastases × Positron Emission Tomography Computed Tomography × Clear all
NCT04143516 2026-03-19

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Memorial Sloan Kettering Cancer Center

Phase 2/3 Recruiting
200 enrolled

Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡